BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1343348)

  • 1. The complement system and primary biliary cirrhosis.
    Benbassat C; Schlesinger M; Shoenfeld Y
    J Clin Lab Immunol; 1992; 38(2):51-61. PubMed ID: 1343348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the immune response in the pathogenesis of primary biliary cirrhosis.
    James SP; Vierling JM; Strober W
    Semin Liver Dis; 1981 Nov; 1(4):322-37. PubMed ID: 7051311
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity?
    Rieger R; Oertelt S; Selmi C; Invernizzi P; Podda M; Gershwin ME
    Ann N Y Acad Sci; 2005 Jun; 1051():211-7. PubMed ID: 16126961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes and (auto)immunity in primary biliary cirrhosis.
    Selmi C; Invernizzi P; Zuin M; Podda M; Seldin MF; Gershwin ME
    Genes Immun; 2005 Oct; 6(7):543-56. PubMed ID: 16034472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of primary biliary cirrhosis: immunological problems.
    Uibo R; Salupere V
    Hepatogastroenterology; 1999; 46(30):3048-52. PubMed ID: 10626158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement profile in primary biliary cirrhosis.
    Schlesinger M; Benbassat C; Shoenfeld Y
    Immunol Res; 1992; 11(2):98-103. PubMed ID: 1431426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties.
    Lindgren S; Eriksson S
    J Lab Clin Med; 1982 May; 99(5):636-45. PubMed ID: 7069268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection and primary biliary cirrhosis.
    Agmon-Levin N; Katz BS; Shoenfeld Y
    Isr Med Assoc J; 2009 Feb; 11(2):112-5. PubMed ID: 19432041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
    Bittencourt PL; Farias AQ; Abrantes-Lemos CP; Goncalves LL; Goncalves PL; Magalhães EP; Carrilho FJ; Laudanna AA; Cançado EL
    J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in chronic liver disease.
    Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
    Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiopathogenesis of primary biliary cirrhosis].
    Encinas Sotillos A; Cerezo López E; Cano JM; Segura Cabral JM; Suárez Parga J; Muro González J
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):64-72. PubMed ID: 7048453
    [No Abstract]   [Full Text] [Related]  

  • 12. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis.
    Amoroso P; Vergani D; Wojcicka BM; McFarlane IG; Eddleston AL; Tee DE; Williams R
    Clin Exp Immunol; 1980 Oct; 42(1):95-8. PubMed ID: 7006876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and primary biliary cirrhosis.
    Mackay IR
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):519-33. PubMed ID: 10976012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathology of primary biliary cirrhosis: thoughts for the millennium.
    Sasaki M; Ansari AA; Nakanuma Y; Coppel RL; Keeffe EB; Gershwin ME
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):1-10. PubMed ID: 10722225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological characteristics of primary biliary cirrhosis patients].
    Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary biliary cirrhosis: does X mark the spot?
    Selmi C; Invernizzi P; Miozzo M; Podda M; Gershwin ME
    Autoimmun Rev; 2004 Nov; 3(7-8):493-9. PubMed ID: 15546796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary biliary liver cirrhosis].
    Sailer S; Lanzer G
    Acta Med Austriaca; 1983; 10(4):101-6. PubMed ID: 6138914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis.
    Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K
    Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.